SCHEMBL4972049

SCHEMBL4972049

CC1CCC(C)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.40
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
TAS1R2 Q8TE23 2/20 0.40
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2B P41595 1/20 0.40
PDPK1 O15530 1/20 0.38
NOTUM Q6P988 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
CYP11B2 P19099 1/20 0.37
DRD2 P14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30130746 1.00 HTR2C (0.40) HTR2CTAS1R3TAS1R1TAS1R2NOS3
SCHEMBL4016333 0.85 SLC6A2 (0.47) TAS1R3TAS1R1TAS1R2NOS3NOS1
SCHEMBL15001000 0.85 TAS1R3 (0.38) HTR2CTAS1R3TAS1R1TAS1R2NOS3
SCHEMBL15000998 0.85 TAS1R3 (0.38) HTR2CTAS1R3TAS1R1TAS1R2NOS3
SCHEMBL8251125 0.85 SLC6A2 (0.47) TAS1R3TAS1R1TAS1R2NOS3NOS1
SCHEMBL15000999 0.85 TAS1R3 (0.38) HTR2CTAS1R3TAS1R1TAS1R2NOS3
SCHEMBL30402212 0.85 SLC6A2 (0.47) TAS1R3TAS1R1TAS1R2NOS3NOS1
SCHEMBL20609657 0.85 TAS1R3 (0.35) HTR2CTAS1R3TAS1R1TAS1R2NOS3
SCHEMBL21694957 0.85 SLC6A2 (0.47) TAS1R3TAS1R1TAS1R2NOS3NOS1
SCHEMBL8253156 0.82 PDPK1 (0.55) PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12275680-B2 Method for producing 1,4-dimethyltetralin SINOCHEM HEBEI FUHENG CO., LTD (CN) 2025-04-15 US claimed
US-12240805-B2 Method for producing 1,4-dimethylnaphthalene SINOCHEM HEBEI FUHENG CO., LTD (CN) 2025-03-04 US claimed
US-20240228408-A1 METHOD FOR PRODUCING 1,4-DIMETHYLTETRALIN SINOCHEM HEBEI FUHENG CO., LTD. (CN) 2024-07-11 US claimed
US-20240228406-A1 METHOD FOR PRODUCING 1,4-DIMETHYLNAPHTHALENE SINOCHEM HEBEI FUHENG CO., LTD. (CN) 2024-07-11 US claimed
EP-4148034-A1 METHOD FOR MANUFACTURING 1,4-DIMETHYLNAPHTHALENE Sinochem Hebei Fuheng Co., Ltd (CN) 2023-03-15 EP claimed
CN-115504849-A Method for producing 1,4-dimethyltetralin 河北中化滏恒股份有限公司 2022-12-23 CN claimed
CN-115504850-A Method for preparing 1,4-dimethylnaphthalene 河北中化滏恒股份有限公司 2022-12-23 CN claimed
WO-2022257261-A1 METHOD FOR PREPARING 1,4-DIMETHYLTETRALIN 河北中化滏恒股份有限公司 2022-12-15 WO claimed
CN-109929328-B Composite ink and preparation method and device thereof TCL科技集团股份有限公司 2021-10-22 CN claimed
US-11069856-B2 Solution for organic EL, method of producing organic EL device and organic EL device JOLED INC. (JP) 2021-07-20 US claimed
US-20200373508-A1 ELECTROLUMINESCENT MATERIAL INK AND ELECTROLUMINESCENT DEVICE THEREOF GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD. (CN) 2020-11-26 US claimed
CN-108948865-B Electroluminescent material ink and electroluminescent device thereof 广东聚华印刷显示技术有限公司 2020-07-10 CN claimed
CN-109929328-A A kind of compound ink and preparation method thereof, device TCL集团股份有限公司 2019-06-25 CN claimed
CN-108948865-A Electroluminescent material ink and its electroluminescent device 广东聚华印刷显示技术有限公司 2018-12-07 CN claimed
JP-9241183-A None JP disclosed
US-12275680-B2 Method for producing 1,4-dimethyltetralin SINOCHEM HEBEI FUHENG CO., LTD (CN) 2025-04-15 US disclosed
US-12275680-B2 Method for producing 1,4-dimethyltetralin SINOCHEM HEBEI FUHENG CO., LTD (CN) 2025-04-15 US disclosed
EP-0351074-A1 Preparation of a dimethyltetralin AMOCO CORPORATION (US) 1990-01-17 EP disclosed
WO-1989012612-A1 PREPARATION OF A DIMETHYLTETRALIN AMOCO CORPORATION (US) 1989-12-28 WO disclosed
US-3997616-A FROM ALKENYLBENZENE, CYCLIZATION CATALYST TEIJIN LIMITED (JA) 1976-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228406-A1 METHOD FOR PRODUCING 1,4-DIMETHYLNAPHTHALENE DHPS, DNPH1, DDAH1 HTR2C 2719/4885TAS1R3 3619/4885TAS1R1 3258/4885
US-12240805-B2 Method for producing 1,4-dimethylnaphthalene DHPS, DNPH1, DDAH1 HTR2C 2719/4885TAS1R3 3619/4885TAS1R1 3258/4885
US-12275680-B2 Method for producing 1,4-dimethyltetralin DPYD, DHFR, MTHFD2 HTR2C 253/4885TAS1R3 4147/4885TAS1R1 3712/4885
US-20240228408-A1 METHOD FOR PRODUCING 1,4-DIMETHYLTETRALIN DPYD, DHFR, PAH HTR2C 167/4885TAS1R3 4280/4885TAS1R1 3939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.